The company will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.

Healthcare distributor and services company Cardinal Health (NYSE:CAH) missed Wall Street’s revenue expectations in Q2 CY2025 ...

Cardinal Health (NYSE:CAH) announced on Tuesday that it has decided to spend roughly $1.9B in cash to acquire Solaris Health, ...

Cardinal Health said on Tuesday its unit would buy Solaris Health and the company would provide about $1.9 billion in cash ...

Cardinal Health logged slightly higher profit and revenue in its fiscal fourth quarter, as recent acquisitions helped to ...

Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization ...

Cardinal Health will provide approximately $1.9 billion in cash to The Specialty Alliance to enable the acquisition.

Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Investing.com - Cardinal Health (NYSE: CAH) reported fourth quarter EPS of $2.08, $0.05 better than the analyst estimate of $2.03. Revenue for the quarter came in at $60.2B versus the consensus ...

Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the ...

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

Drug distributor Cardinal Health said on Tuesday it would acquire Solaris Health for about $1.9 billion in cash.